EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+3.05%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.25B
AUM Growth
+$1.25B
(+15%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
12.52%
Top 10 Holdings %
Top 10 Hldgs %
49.35%
Holding
117
New
34
Increased
30
Reduced
22
Closed
15
Top Buys
| 1 |
Labcorp
LH
|
$36.1M |
| 2 |
Ascendis Pharma
ASND
|
$32.4M |
| 3 |
Community Health Systems
CYH
|
$25.3M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$24.5M |
| 5 |
Icon
ICLR
|
$18.8M |
Top Sells
| 1 |
Qiagen
QGEN
|
$26.2M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$25.8M |
| 3 |
Organon & Co
OGN
|
$21.2M |
| 4 |
Danaher
DHR
|
$17.3M |
| 5 |
AMN Healthcare
AMN
|
$17.1M |
Sector Composition
| 1 | Healthcare | 93.33% |
| 2 | Industrials | 1.35% |
| 3 | Financials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Guardant Health
GH
$8.41B
| $12.5M | 0.87% | 100,361 +98,552 | +5,448% | +$12.3M |
|
27
Natera
NTRA
$23.1B
| $12.5M | 0.86% | 112,189 +102,875 | +1,105% | +$11.5M |
|
28
Sanofi
SNY
$121B
| $12.5M | 0.86% | +259,128 | New | +$12.5M |
|
29
Elevance Health
ELV
$71.8B
| $11.8M | 0.82% | 31,628 +21,496 | +212% | +$8.01M |
|
|
ZGNX
30
DELISTED
Zogenix, Inc.
ZGNX
| $11.8M | 0.81% | 774,591 +278,731 | +56% | +$4.23M |
|
|
TARO
31
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $11.4M | 0.79% | 179,366 +5,117 | +3% | +$326K |
|
32
Alnylam Pharmaceuticals
ALNY
$58.5B
| $11.2M | 0.77% | 59,233 +8,097 | +16% | +$1.53M |
|
33
Exelixis
EXEL
$10.1B
| $10.9M | 0.75% | 516,307 +336,307 | +187% | +$7.11M |
|
|
MGLN
34
DELISTED
Magellan Health Services, Inc.
MGLN
| $9.9M | 0.68% | 104,700 | – | – |
|
35
Humana
HUM
$36.5B
| $9.39M | 0.65% | 24,083 +5,427 | +29% | +$2.12M |
|
36
HCA Healthcare
HCA
$94.5B
| $9.31M | 0.64% | 38,366 +30,052 | +361% | +$7.29M |
|
37
Centene
CNC
$14.3B
| $8.79M | 0.61% | 141,107 +73,107 | +108% | +$4.56M |
|
|
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $8.6M | 0.6% | 230,744 +113,282 | +96% | +$4.22M |
|
39
Revvity
RVTY
$10.5B
| $8.16M | 0.56% | +47,081 | New | +$8.16M |
|
|
NSTG
40
DELISTED
NanoString Technologies, Inc.
NSTG
| $8.1M | 0.56% | +168,668 | New | +$8.1M |
|
41
HealthEquity
HQY
$7.72B
| $7.41M | 0.51% | 114,378 -83,122 | -42% | -$5.38M |
|
|
42
Qiagen
QGEN
$10.1B
| $7.4M | 0.51% | 143,109 -507,926 | -78% | -$26.2M |
|
43
iRhythm Technologies
IRTC
$5.46B
| $6.67M | 0.46% | +113,854 | New | +$6.67M |
|
44
GoHealth
GOCO
$81.7M
| $6.35M | 0.44% | 1,261,723 +1,192,824 | +1,731% | +$6M |
|
|
HRC
45
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $4.5M | 0.31% | +30,000 | New | +$4.5M |
|
46
Lexicon Pharmaceuticals
LXRX
$400M
| $4.2M | 0.29% | 872,694 +643,405 | +281% | +$3.09M |
|
47
ARK Innovation ETF
ARKK
$7.45B
| $3.87M | 0.27% | 35,000 -50,000 | -59% | -$5.53M |
|
|
SRGA
48
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $3.82M | 0.26% | 3,508,536 -373,560 | -10% | -$407K |
|
49
DexCom
DXCM
$29.5B
| $3.5M | 0.24% | 6,401 -3,124 | -33% | -$1.71M |
|
50
SI-BONE Inc
SIBN
$719M
| $3.21M | 0.22% | +150,000 | New | +$3.21M |
|